Learn More
BACKGROUND On the basis of the results of the randomised clinical trial HPTN 052 and observational studies, WHO has recommended that antiretroviral therapy be offered to all HIV-infected individuals with uninfected partners of the opposite sex (serodiscordant couples) to reduce the risk of transmission. Whether or not such a public health approach is(More)
BACKGROUND Late diagnosis of HIV infection is common. We aim to assess the proportion of newly diagnosed HIV cases receiving timely baseline CD4 count testing and the associated factors in China. METHODS Data were extracted from the Chinese HIV/AIDS Comprehensive Response Information Management System. Adult patients over 15 years old who had been newly(More)
BACKGROUND Antiretroviral therapy (ART) and condom use have been proven to reduce the risk of sexual transmission of human immunodeficiency virus (HIV) among HIV sero-different couples, but its full implementation remains a challenge. This study aims to assess HIV seroconversion rate of HIV-negative spouse and its associated risk factors among HIV(More)
BACKGROUND Multistage, stepwise HIV testing and treatment procedures can result in lost opportunities to provide timely antiretroviral therapy (ART). Incomplete engagement of patients along the care cascade translates into high preventable mortality. We aimed to identify whether a structural intervention to streamline testing and linkage to HIV health care(More)
OBJECTIVE To analyze factors associated with antiretroviral therapy (ART) initiation and its timeliness among HIV sero-discordant couples in high HIV prevalence regions in China. METHODS Data from the national HIV epidemiology and treatment databases by Dec 31, 2013 were used to collect HIV serodiscordant couples' baseline and follow-up informations in 40(More)
OBJECTIVE This article endeavors to describe the key indicators of follow-up services for people living with HIV/AIDS (PLWHA) in China from 2008 to 2014. METHODS All data were extracted from the National Comprehensive HIV/AIDS database and cleaned, based on three key indicators (proportion of follow-up of PLWHA, CD(4) testing of PLWHA and HIV antibody(More)
BACKGROUND In Guangxi Zhuang Autonomous Region, China, an estimated 80% of newly-identified antiretroviral therapy (ART)-eligible patients are not engaged in ART. Delayed ART uptake ultimately translates into high rates of HIV morbidity, mortality, and transmission. To enhance HIV testing receipt and subsequent treatment uptake in Guangxi, the Chinese(More)
  • 1